Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

PaperCitations, authors & open-access status

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 493 citations, 2007 year and closed oa status.

493
Citations
2007
Year
closed
OA Status

Related on ScholarIQ

Peter Strang
Author
The Lancet Oncology
Journal
Radiopharmaceutical Chemistry and Applications
Topic
Radiopharmaceutical Chemistry and Applications
Topic
Prostate Cancer Treatment and Research
Topic
Effects of Radiation Exposure
Topic
470M+ articles · free account